3Hedenius P.The use of heparin in internal diseases.Acta Med Scand,1941,107:170-177.
4Duke R J,Bolch RF,Turpie AG,et al.Intravenous heparin for prevention of stroke progression in acute partial stable stroke.Ann Int Med,1986,105:825-828.
5Adams HP Jr.Emergent use of anticoagulation for treatment of patients with ischemic stroke.Stroke,2002,33:856-861.
6Berge E,Abdelnoor M,Nakstad PH,et al.Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a double-blind randomised study.HAEST Study Group.Heparn in Acute Embolic Stroke Trial.Lancet,2000,355:1205-1210.
8Sandercock P,Counsell C,Stobbs SL.Low-molecular-weight heparns or heparnoids versus standard unfractionated heparin for acute ischaemic stroke.Cochrane Database Syst Rev,2005,(2):CD000119.
9Kay R,Wong KS,Yu YL,et al.Low-molecular-weight heparin for the treatment of acute ischemic stroke.N Engl J Med,1995,333:1588-1593.
10The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.Low molecular weight heparnoid,ORG 10172 (danaparoid),and outcome after acute ischemicstroke:a randomized controlled trial.JAMA,1998,279:1265-1272.
